Immunotherapy

Immunotherapy is a revolutionary approach in oncology that activates the body's own immune system to fight cancer cells. This treatment method transforms the concept of cancer therapy, offering patients not just a chance for remission but also an improvement in quality of life.

How does immunotherapy work?

The human immune system is a complex mechanism capable of recognizing and destroying 'enemies' such as viruses and bacteria. However, cancer cells can hide from the immune response by suppressing its activity. Immunotherapy removes these 'disguises,' allowing the immune system to attack the tumor.

Different approaches to immunotherapy include:

• Checkpoint inhibitors: Drugs like pembrolizumab or nivolumab remove the block on immune cells, activating them to destroy the tumor. Studies have shown that they increase the survival rate of patients with metastatic lung cancer by 30-40%.
• CAR-T cell therapy: This method involves modifying a patient's own T-cells to target the tumor specifically. CAR-T therapy is particularly effective in treating certain types of leukemias and lymphomas, achieving remission in 50-80% of patients.
• Cancer vaccines: Personalized vaccines are being developed that train the immune system to attack specific tumor antigens.

Who can benefit from immunotherapy?

Immunotherapy is not suitable for everyone but is especially effective in tumors that:

• have a high mutational burden, such as melanoma or lung cancer.
• produce PD-L1 proteins, which suppress the immune response. Testing for this biomarker can predict the success of therapy.
• are recurrent or resistant to standard treatments, such as chemotherapy. According to the National Cancer Institute USA, patients with melanoma who received PD-1 inhibitors have a 5-year survival rate of about 40%, significantly higher than with traditional methods.

Immunotherapy is a complex and high-tech method that requires accurate diagnosis and access to the best clinical protocols. Alisa Health Group offers a unique opportunity to receive treatment in world-leading oncology clinics.

Why choose Alisa Health Group?

• Individual approach: We work with patients at all stages—from diagnosis to selecting the most effective immunotherapy method.
• Access to innovations: Our partner clinics participate in international clinical studies, giving patients access to new drugs and technologies.
• Support at every step: We organize the trip, translate medical documents, and consult with the best specialists in oncology.

Myths and facts about immunotherapy

• Myth: Immunotherapy causes severe side effects.
• Fact: Side effects are usually related to the activation of the immune system, such as mild fatigue or inflammation, but they are managed by experienced doctors.
• Myth: It is an experimental method.
• Fact: Immunotherapy has proven its effectiveness and is included in official treatment protocols for a number of cancers.
• Myth: It is only suitable for late stages.
• Fact: Immunotherapy is used in early stages, especially in combination with other treatment methods, such as surgery or radiation therapy.

Immunotherapy is a new chapter in the fight against cancer, changing the lives of patients. Thanks to its precision and individualized approach, many people have a real chance at long-term remission.

If you want to learn more about the possibilities of immunotherapy or consult with specialists, Alisa Health Group is always ready to assist you in this important step.